The DOI matches its Crossref record; 23 of the 23 references it cites were found in a registry or an index.
Pre-morbid characteristics and co-morbidity of methamphetamine users with and without psychosis
Abstract
Background. The long-term use of methamphetamine (MAMP) can result in psychosis but it is not clear why some individuals develop psychotic symptoms, while others use MAMP regularly over long periods and remain unscathed. We set out to characterize MAMP users and to examine the relationship of pre-morbid personality, pre-morbid social function and other psychiatric disorders to MAMP psychosis. Method. Four hundred and forty-five amphetamine users were recruited from a psychiatric hospital and a detention centre in Taipei, and were assessed with the Diagnostic Interview for Genetic Studies (DIGS). Their parents were interviewed with the Premorbid Schizoid and Schizotypal Traits (PSST) and the Premorbid Social Adjustment (PSA) schedules. Pre-morbid characteristics and psychiatric co-morbidity were compared between the MAMP users with a lifetime diagnosis of MAMP psychosis and those without. Results. The MAMP users with psychosis presented a clinical picture which mimicked the positive symptoms of schizophrenia: 85% had auditory hallucinations; 71% persecutory delusions; 63% delusions of reference. Compared with their non-psychotic counterparts, these MAMP users were younger at first MAMP use, used larger amounts of MAMP, had a significantly higher mean PSST score, and higher rates of major depressive disorder, alcohol dependence and antisocial personality disorder. Conclusions. Earlier and larger use of MAMP was associated with increased risk of psychosis. Our data are also compatible with the view that pre-morbid schizoid/schizotypal personality predisposes MAMP users to develop psychosis, and that the greater the personality vulnerability, the longer the psychosis will persist.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“First, it must account for the excessive dopamine neurotransmission that has been associated with the psychotic symptoms of schizophrenia.”
From Schizophrenia, myelination, and delayed corollary discharges: a hypothesis (2012) · cites this paper as [3]
Citations
Cites
Diagnostic and Statistical Manual of Mental Disorders
Williams, J. B. W., & First, M. B. (2013) · Oxford University Press eBooks · doi:10.1093/acrefore/9780199975839.013.104 · Cited by 109,845
Regier, D. A. (1990) · JAMA · doi:10.1001/jama.1990.03450190043026 · Cited by 3,962
Kessler, R. C. (1997) · Archives of General Psychiatry · doi:10.1001/archpsyc.1997.01830160031005 · Cited by 2,085
Diagnostic Interview for Genetic Studies
Nürnberger, J. I. (1994) · Archives of General Psychiatry · doi:10.1001/archpsyc.1994.03950110009002 · Cited by 2,075
Schizotaxia, schizotypy, schizophrenia.
Meehl, P. E. (1962) · American Psychologist · doi:10.1037/h0041029 · Cited by 2,036
The Prevalence of Psychiatric Disorders in Patients With Alcohol and Other Drug Problems
Ross, H. E. (1988) · Archives of General Psychiatry · doi:10.1001/archpsyc.1988.01800350057008 · Cited by 724
Cannabis Abuse and the Course of Recent-Onset Schizophrenic Disorders
LINSZEN, D. H. (1994) · Archives of General Psychiatry · doi:10.1001/archpsyc.1994.03950040017002 · Cited by 665
Amphetamine Psychosis: A "Model" Schizophrenia Mediated by Catecholamines
Snyder, S. H. (1973) · American Journal of Psychiatry · doi:10.1176/ajp.130.1.61 · Cited by 588
Heterogeneity of Psychiatric Diagnosis in Treated Opiate Addicts
Rounsaville, B. J. (1982) · Archives of General Psychiatry · doi:10.1001/archpsyc.1982.04290020027006 · Cited by 558
Prevalence of psychiatric disorders in Taiwan defined by the Chinese Diagnostic Interview Schedule
Hwu, H., Yeh, E., & Chang, L. ‐. (1989) · Acta Psychiatrica Scandinavica · doi:10.1111/j.1600-0447.1989.tb08581.x · Cited by 472
Comparison of Amphetamine Psychosis and Schizophrenia
Bell, D. S. (1965) · The British Journal of Psychiatry · doi:10.1192/bjp.111.477.701 · Cited by 328
Chen, W. J., Liu, S. K., Chang, C., Lien, Y.-J., Chang, Y., & Hwu, H. (1998) · American Journal of Psychiatry · doi:10.1176/ajp.155.9.1214 · Cited by 260
Pre-morbid Adjustment and Personality in Psychosis
Foerster, A., Lewis, S. W., Owen, M. J., & Murray, R. M. (1991) · The British Journal of Psychiatry · doi:10.1192/bjp.158.2.171 · Cited by 198
Self-citationThe Search for Symptoms Predictive of Schizophrenia
Chapman, L. J., & Chapman, J. P. (1987) · Schizophrenia Bulletin · doi:10.1093/schbul/13.3.497 · Cited by 174
Subtypes of Drug Abuse With Psychosis
Tsuang, M. T. (1982) · Archives of General Psychiatry · doi:10.1001/archpsyc.1982.04290020013003 · Cited by 161
Amphetamine Misuse: International Perspectives on Current Trends
Klee, H. (1997) · Cited by 158
The Structure of DSM-III-R Schizotypal Personality Disorder Diagnosed by Direct Interviews
Battaglia, M., Cavallini, M. C., Macciardi, F. M., & Bellodi, L. (1997) · Schizophrenia Bulletin · doi:10.1093/schbul/23.1.83 · Cited by 63
Chronic Methamphetamine Intoxication Model of Schizophrenia in Animals
Machiyama, Y. (1992) · Schizophrenia Bulletin · doi:10.1093/schbul/18.1.107 · Cited by 52
Time trend of substance use among adolescent students in Taiwan, 1991-1996.
Chou, P., My, L., My, L., Ml, H., & Hj, C. (1999) · PubMed · Cited by 39
Childhood schizotypy and positive symptoms in schizophrenic patients predict schizotypy in relatives
Mata, I., Sham, P. C., Gilvarry, C. M., Jones, P. B., Lewis, S. W., & Murray, R. M. (2000) · Schizophrenia Research · doi:10.1016/s0920-9964(99)00222-4 · Cited by 33
Self-citationEffects of methamphetamine and ethanol on learning and brain neurotransmitters in rats
Yamamura, T., Hishida, S., Hatake, K., Taniguchi, T., & Ouchi, H. (1992) · Pharmacology Biochemistry and Behavior · doi:10.1016/0091-3057(92)90131-x · Cited by 20
Todzy, I., Coper, H., & Fernandes, M. S. (1978) · Psychopharmacology · doi:10.1007/bf00427748 · Cited by 19
Alcohol Addiction of Methamphetamine Abusers in Japan
Yamamura, T., Hisida, S., & Hatake, K. (1991) · Journal of Forensic Sciences · doi:10.1520/jfs13086j · Cited by 18
Cited by
Sorted by citations
A review of the clinical pharmacology of methamphetamine
Cruickshank, C., & Dyer, K. R. (2009) · Addiction · doi:10.1111/j.1360-0443.2009.02564.x · Cited by 802
Major physical and psychological harms of methamphetamine use
DARKE, S., KAYE, S., McKETIN, R., & DUFLOU, J. (2008) · Drug and Alcohol Review · doi:10.1080/09595230801923702 · Cited by 675
Neurocognitive Effects of Methamphetamine: A Critical Review and Meta-analysis
Scott, J. C., Woods, S. P., Matt, G. E., Meyer, R. A., Heaton, R. K., Atkinson, J. H., & Grant, I. (2007) · Neuropsychology Review · doi:10.1007/s11065-007-9031-0 · Cited by 669
Comorbidity between substance use disorders and psychiatric conditions.
Schuckit, M. (2006) · Addiction · doi:10.1111/j.1360-0443.2006.01592.x · Cited by 434
Implications of Chronic Methamphetamine Use: A Literature Review
Meredith, C. W., Jaffe, C., Ang-Lee, K., & Saxon, A. J. (2005) · Harvard Review of Psychiatry · doi:10.1080/10673220591003605 · Cited by 396
Metadata
- Authors
- CHEN, C.-K., LIN, S.-K., SHAM, P. C., BALL, D., LOH, E.-W., HSIAO, C.-C., CHIANG, Y.-L., REE, S.-C., LEE, C.-H., & MURRAY, R. M.
- Affiliations
- Chang Gung Memorial Hospital (TW)
- Venue
- Psychological Medicine
- Publisher
- Cambridge University Press (CUP)
- Published
- 2003-10-30
- Volume
- 33
- Issue
- 8
- Pages
- 1407-1414
- ISSN
- 0033-2917 (ISSN-L)
- 1469-8978
- OpenAlex
- W2108964872
- Cited by
- 295
- References
- 23
- Citations by year
- 2026: 4 · 2025: 6 · 2024: 9 · 2023: 5 · 2022: 8 · 2021: 8 · 2020: 28 · 2019: 14 · 2018: 14 · 2017: 7 · 2016: 13 · 2015: 15 · 2014: 21 · 2013: 19 · 2012: 18
- FWCI
- 5.93
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Psychological Medicine (publishedVersion)
- PubMed (publishedVersion)
- The HKU Scholars Hub (University of Hong Kong) (submittedVersion)
- Research Portal (King's College London) (submittedVersion)
- Topics
- Health Sciences › Medicine › Psychiatry and Mental health › Schizophrenia research and treatment
- Health Sciences › Medicine › Epidemiology › Substance Abuse Treatment and Outcomes
- Life Sciences › Pharmacology, Toxicology and Pharmaceutics › Toxicology › Forensic Toxicology and Drug Analysis
- Keywords
- methamphetamine, amphetamine psychosis, premorbid personality, schizoid personality disorder, schizotypy, psychiatric comorbidity, major depressive disorder, alcoholism, antisocial personality disorder, auditory hallucinations, persecutory delusions, delusions of reference, age at first use, dosage
- MeSH terms
- Adolescent, Adult, Alcoholism, Central Nervous System Stimulants, Antisocial Personality Disorder, Major Depressive Disorder, Depressive Disorder, Major, Disease Susceptibility, Female, Hospitals, Psychiatric, Humans, Male, Methamphetamine, Personality Assessment, Prisons, Psychiatric Status Rating Scales, Psychoses, Substance-Induced, Risk Factors, Schizoid Personality Disorder, Schizophrenia, Schizophrenic Psychology, Social Adjustment, Taiwan, Comorbidity, Causality, Amphetamine-Related Disorders
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review